Drugs / Extracellular secretomes
Extracellular secretomes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06813027 | Jan 2023 → Jan 2026 overdue | vitiligo | University of Jordan | Active not recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Extracellular secretomes | “Extracellular secretomes ( extracellular vesicles "EV") derived from mesenchymal stroma cells (MSCs)” NCT06813027 ↗ |
| Known as | EV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06813027 ↗ |
| Known as | extracellular vesicles | “Extracellular secretomes ( extracellular vesicles "EV") derived from mesenchymal stroma cells (MSCs)” NCT06813027 ↗ |
| Modality | Other / unclassified | “extracellular vesicles "EV"” NCT06813027 ↗ |
| Route | Other | “when injected perilesional repeatedly” NCT06813027 ↗ |